Riociguat and Vardenafil interaction

Riociguat and Vardenafil: both prescribing labels flag this combination with the strongest language, such as a contraindication, a boxed warning, or an instruction to avoid it.

Major

Do not combine without a prescriber's guidance. The label language below is the strongest FDA uses.

What the FDA labels say

From the Riociguat (Adempas) label · effective 2026-08-13

Major

Phosphodiesterase Inhibitors Concomitant administration of Adempas with specific PDE-5 inhibitors (such as sildenafil, tadalafil, or vardenafil) or nonspecific PDE-5 inhibitors (such as dipyridamole or theophylline) is contraindicated [see Dosage and Administration (2.6), Drug Interactions ( 7.1 ) and Clinical Pharmacology ( 12.2 )].

Contraindicationsby drug classView label on DailyMed
Moderate

PDE Inhibitors: Co-administration of Adempas with specific PDE-5 inhibitors (such as sildenafil, tadalafil, or vardenafil) and nonspecific PDE inhibitors (such as dipyridamole or theophylline), is contraindicated because of hypotension.

Drug interactionsby drug classView label on DailyMed
Minor

Clinical experience with co-administration of Adempas and other phosphodiesterase inhibitors (for example, milrinone, cilostazole, roflumilast) is limited.

Drug interactionsby drug classView label on DailyMed

From the Vardenafil (Vardenafil Hydrochloride) label · effective 2026-08-27

Major

Administration with guanylate cyclase (GC) stimulators, such as riociguat ( 2.4 , 4.2 )

Contraindicationsnames RiociguatView label on DailyMed
Major

Guanylate Cyclase (GC) Stimulators Do not use vardenafil hydrochloride tablets in patients who are using a GC stimulator, such as riociguat.

Contraindicationsnames RiociguatView label on DailyMed
Moderate

When vasodilators are used in combination, an additive effect on blood pressure may be anticipated.

Warnings and precautionsby drug classView label on DailyMed
Minor

Left Ventricular Outflow Obstruction Patients with left ventricular outflow obstruction, (for example, aortic stenosis and idiopathic hypertrophic subaortic stenosis) can be sensitive to the action of vasodilators including PDE5 inhibitors.

Warnings and precautionsby drug classView label on DailyMed
Minor

PDE5 inhibitors, including vardenafil hydrochloride tablets, and alpha-adrenergic blocking agents are both vasodilators with blood-pressure lowering effects.

Warnings and precautionsby drug classView label on DailyMed

Taking more than these two? Interactions stack. Check your whole list at once; it stays in your browser.

Open in the checker

Not medical advice. Interaction Checker quotes FDA label text and NIH fact sheets. Whether an interaction matters for you depends on doses, timing, kidney and liver function, and other conditions. Confirm with a pharmacist or prescriber.